Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction

NCT00226759 is registered in ClinicalTrials.gov with Omeros Corporation as lead sponsor.

NCT NCT00226759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction
Lead sponsor
Omeros Corporation
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
March 31, 2011
Enrollment
321 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

knee injuries